Correlation Between Inhibrx and Advantest

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Advantest at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Advantest into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Advantest, you can compare the effects of market volatilities on Inhibrx and Advantest and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Advantest. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Advantest.

Diversification Opportunities for Inhibrx and Advantest

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Inhibrx and Advantest is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Advantest in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Advantest and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Advantest. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Advantest has no effect on the direction of Inhibrx i.e., Inhibrx and Advantest go up and down completely randomly.

Pair Corralation between Inhibrx and Advantest

Given the investment horizon of 90 days Inhibrx is expected to under-perform the Advantest. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 1.1 times less risky than Advantest. The stock trades about -0.08 of its potential returns per unit of risk. The Advantest is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  4,347  in Advantest on September 18, 2024 and sell it today you would earn a total of  1,903  from holding Advantest or generate 43.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.41%
ValuesDaily Returns

Inhibrx  vs.  Advantest

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Advantest 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Advantest are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Advantest reported solid returns over the last few months and may actually be approaching a breakup point.

Inhibrx and Advantest Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and Advantest

The main advantage of trading using opposite Inhibrx and Advantest positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Advantest can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Advantest will offset losses from the drop in Advantest's long position.
The idea behind Inhibrx and Advantest pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device